Lung cancer deaths cut in half with AstraZeneca pill, large trial finds

Patients with early-stage lung cancer who took Tagrisso daily for three years had a 51% lower risk of death from the disease.

View the Link Below:

https://www.nbcnews.com/health/cancer/lung-cancer-deaths-cut-half-astrazeneca-pill-large-trial-finds-rcna87705

#geriatriccare #geriatric #homecare #seniorcare #geriatricaremanagment #newyork #newyorkcity #longisland #patientadvocate

#lungcancer #cancer #astrazeneca #tagrisso #trial #patientadvocatesofamerica